Top compounds associated with response to SMYD3


Feature Type Standardized
Nominal ANOVA
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.0008
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.16 0.0008
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.12 0.001
mRNA GSK269962A GDSC1000 pan-cancer AAC 0.1 0.001
mRNA Imatinib CTRPv2 pan-cancer AAC 0.12 0.001
mRNA neratinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.24 0.002
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.11 0.002
Download CSV